Most trust literature investigates missing trust and health care underuse. The authors show that mistrust also leads to health care overuse, a rapidly growing problem in the United States.
ABSTRACT
Research about mistrust in health care often relies on the narrative that lacking trust causes underuse of health care services. This narrative seemed to hold up in the COVID-19 pandemic era, when mistrust in systems and providers led to widely recognized vaccine hesitancy and reluctance to seek care. In this review, we suggest that the “mistrust leads to underuse” narrative is important but incomplete, as mistrust in health care may also cause patients to overuse health care services. We searched the literature for studies, meta-analyses, and interviews that assessed the effect of patient trust on health care utilization. Although overuse literature is sparse, surveys and physician interviews indicate that patients who do not trust their clinicians may seek multiple opinions on the same diagnosis and utilize more costly interventions that are not recommended. Physicians also report being more likely to utilize extraneous tests and medications when patients do not trust them. Hence, problems of trust may lead to both underuse and overuse of health care services. We postulate several factors that may influence whether a mistrustful patient underuses or overuses health care resources, including personal characteristics, environmental characteristics, and levels of analysis, and we encourage more investigation about mistrust and health care overutilization.
Am J Manag Care. 2023;29(8):388-392. https://doi.org/10.37765/ajmc.2023.89404
Takeaway Points
Most trust literature centers on how mistrust leads patients to underuse health care but rarely considers other outcomes, such as overuse—that is, seeking out care that is unnecessary, costly, and potentially harmful.
Popular narratives about patient mistrust in health care tend to emphasize the risks of underusing health care services. Underuse was frequently illustrated in media narratives featuring Americans with trust concerns declining medical care or vaccination for COVID-19.1 Beyond COVID-19, peer-reviewed commentaries and perspective pieces underscore this relationship with titles and theses such as “Mistrust of Health Care Organizations Is Associated With Underutilization of Health Services” and “Underuse of Breast Cancer Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical Mistrust.”2,3 These concerns are evidence based and legitimate, but a fuller consideration of the trust literature reveals that underuse tells an incomplete story.
Both underuse and overuse are targets of managed care’s attention. Although underuse may appear to be cost saving for risk bearers at first glance, the downstream effects of underusing routine or preventive care can lead to costly health care interactions and diminished health. Meanwhile, overuse is often synonymous with low- or no-value care. Thus, to the extent that bolstering patient trust may facilitate appropriate consumption of health care, understanding the complexity of the relationship between trust and utilization should be a core concern for managed care.
Our goals here are 3-fold: (1) to call readers’ attention to an apparent puzzle in the trust and health services literature: low trust or mistrust, which we refer to as “missing” trust, has been associated with both patient overuse and underuse of medical resources; (2) to propose hypotheses to reconcile the puzzle; and (3) to suggest future research directions that can clarify the relationship between missing trust and utilization.
Studying Missing Trust
A large number of health services research studies on trust proceed with the goal of identifying the effects of missing patient trust on health care utilization.4 We reconsidered that literature as 2 subliteratures, according to our interests: (1) those in which missing trust was associated with underuse, defined as the avoidance of clinically appropriate care, and (2) those in which missing trust was associated with overuse, defined as utilization of medical resources that were not medically necessary or were low value. The underuse literature includes considerably more, and more rigorous, studies than the overuse literature, which may owe to the difficulties of measuring overuse. That said, there is ample enough theory and evidence linking missing trust to overuse to prompt a reconsideration of the relationship between patient trust and utilization. The Table [part A and part B]2,3,5-19 provides an illustrative (rather than comprehensive) snapshot of the 2 subliteratures, featuring original research published from any country between 2000 and 2022.
Missing Trust and Health Care Underuse
The underuse literature is a fairly well-characterized field with validated tools showing that missing trust can lead to underutilization of medical resources across various outcomes and patient populations. This literature relies heavily on the Medical Mistrust Index, a 14-item validated scale to measure patient perception of deceit, level of caution, beliefs about privacy, and confidence in the health care system.2
Most studies supporting the underuse narrative are survey based and investigate patient trust or mistrust in either the health care system, individual providers, or both; they seek to correlate mistrust with varied measures of underutilization. Such studies have found that patients who mistrust the health care system, their provider, or both tend to take less advantage of health care resources through underuse of the following measures: receiving standard-of-care interventions,3,11 filling prescriptions,2 adhering to medications,9,10 screening for cancer or other chronic conditions,6 participating in medical research,7 visiting a primary care physician,5 receiving vaccines,13 taking physician advice,2 attending follow-up appointments,2 and seeking care when needed.2 Underuse research also tends to focus on minority patient populations. Seven of the 11 underuse studies we identified surveyed racial and ethnic minority populations.6-8,10-13
Missing Trust and Health Care Overuse
Less remarked upon are a number of studies that have directly investigated how patient trust may lead to health care overuse. This smaller body of research consists primarily of qualitative interview-based studies with physicians and patients and a smattering of survey-based studies that explore how patients’ trust in the physician or health care system affects their medical decision-making.
For example, in 2 studies involving patients with medical conditions for which conservative management is indicated, patients who trusted their physician were shown to be more likely to choose conservative management over costlier surgical interventions.14,17
In Poland, a survey carried out in 2015-2016 found that patients with increased trust in the health care system, as assessed by a 5-item questionnaire, were less likely to report wanting to seek multiple physicians’ opinions on the same diagnosis.20
In interview studies, many physicians drew from personal experience to suggest that a lack of patient trust contributes to overuse.16,18,19
A 2019 review by Fritz and Holton entitled “Too Much Medicine: Not Enough Trust?” explored the potential relationship between trust and overuse of health care, claiming that lack of patient trust in their physician contributes to overuse.21 Prior evidence has shown that continuity of care increases patients’ trust in their physician.22 On this basis, Fritz and Holton use continuity of care as a proxy for trust and cite studies that demonstrate a correlation between increased continuity of care and decreased overuse.
These overuse studies advance several claims regarding the relationship between trust and medical overuse. First, patients are more likely to accept conservative medical recommendations from a physician whom they trust, thus decreasing overuse.14,17 Second, patients who trust their physician are less likely to seek multiple opinions about the same diagnosis, also decreasing overuse. Finally, increased patient trust makes physicians more likely to follow their clinical judgment rather than order extraneous interventions when they perceive their patients desire them.16,18,19
Although most of the underuse literature has centered on marginalized patient populations, and particularly racial minorities, the minority status of patients was generally ignored in the trust-overuse literatures. When studying how missing trust may lead to overuse, studies commonly use representative participant samples or predominantly nonmarginalized patients. We caution readers against assuming that the relationship between missing trust and underuse is a function of racial minority status. Doing so would make a fundamental attribution error, in which outcomes driven by situational factors are falsely attributed to an individual’s inherent traits. Even if the propensity to underuse does correlate with a patient’s minority status, this more likely reflects the individual’s relationship with the health care system, which is a byproduct of their lived experience, history, and systemic discrimination, rather than an insight about the minority status itself.
Reconciling the Puzzle
So, could it be that missing trust leads patients to both overuse and underuse? We propose 3 hypotheses, which are not mutually exclusive. Testing these hypotheses should be a priority for future research on patient trust.
Unobserved patient characteristics. Studies of the relationship between missing trust and utilization rarely make use of randomization or other research designs fit for causal inference. As a result, a leading hypothesis is that other variables influence whether patients who lack trust will underuse or overuse health care. Health literacy, for instance, may be a modifier, determining whether overuse or underuse is the behavioral response to missing trust. Among people with low levels of trust in the health care system or provider, those with low literacy may not understand the purpose of an intervention and therefore underuse, whereas those with high health literacy may know (or believe they know) what to request and therefore overuse. To test this hypothesis, studies to quantify and compare levels of health literacy in addition to trust, and perhaps other variables, among patients who overuse and underuse health care are needed.
Unobserved environmental characteristics. A second hypothesis postulates that the same patient may overuse or underuse medical resources depending on their situation. This is partly supported by our review, in which underuse studies measured mostly nonurgent outcomes such as medication refills and attending appointments (the overuse literature is too sparse to make general claims about the nature of outcomes studied). Future research, such as a survey asking patients their level of willingness to utilize a variety of interventions, could help to strengthen this hypothesis.
Levels of analysis. A third hypothesis is that the trustee under study affects whether patients overuse or underuse. For example, missing trust in an individual provider may lead a patient to demand testing or imaging to confirm a doctor’s diagnosis, whereas missing trust in a health care system may lead to patients to “steer clear” entirely, and therefore underuse. We noted that the majority of the trust/underuse literature assesses trust in health care systems, whereas the overuse literature focuses more squarely on trust in individual providers. However, more studies, especially on overuse, are needed to determine whether trends in utilization change based on whether the trustee in question is the health care system or the provider.
Generally, future research on the relationship between patient trust and utilization should be strengthened in several ways. Research designs that allow for causal inference should be prioritized, including longitudinal designs. Close attention should be paid to sample demographics, and reporting thereof, to avoid the propagation of logical fallacies related to marginalized statuses. Additional attention should be paid to the measurement of overuse of medical resources as an outcome of interest. Finally, research on what “too much trust” might yield by way of underuse or overuse is also warranted, as it seems reasonable that it too could yield nonoptimal utilization.
Author Affiliations: New York University Grossman School of Medicine (ERW, AT, MP, LT), New York, NY.
Source of Funding: None.
Author Disclosures: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Authorship Information: Concept and design (LT); acquisition of data (ERW, AT); analysis and interpretation of data (ERW, AT, LT); drafting of the manuscript (ERW, AT, MP); critical revision of the manuscript for important intellectual content (ERW, AT, MP, LT); statistical analysis (LT); provision of patients or study materials (LT); administrative, technical, or logistic support (LT); and supervision (MP).
Address Correspondence to: Elise R. Warda, BS, New York University Grossman School of Medicine, Translational Research Building, 227 E 30th St, 6th Floor, New York, NY 10016. Email: Elise.Warda@nyulangone.org.
REFERENCES
1. COVID-19 National Preparedness Collaborators. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. Lancet. 2022;399(10334):1489-1512. doi:10.1016/S0140-6736(22)00172-6
2. LaVeist TA, Isaac LA, Williams KP. Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009;44(6):2093-2105. doi:10.1111/j.1475-6773.2009.01017.x
3. Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H. Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol. 2009;27(31):5160-5167. doi:10.1200/JCO.2009.22.9773
4. Platt J, Taylor LA. Fifty years of trust research in health care: what does it mean for policymakers? Milbank Memorial Fund. January 24, 2023. Accessed March 26, 2023. https://www.milbank.org/2023/01/fifty-years-of-trust-research-in-health-care-what-does-it-mean-for-policymakers/
5. Goepp JG, Chin NP, Massad J, Edwards LA. Pediatric emergency department outreach: solving medical problems or revealing community solutions? J Health Care Poor Underserved. 2004;15(4):522-529. doi:10.1353/hpu.2004.0060
6. Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: psychometric properties and association with breast cancer screening. Prev Med. 2004;38(2):209-218. doi:10.1016/j.ypmed.2003.09.041
7. Bussey-Jones J, Garrett J, Henderson G, Moloney M, Blumenthal C, Corbie-Smith G. The role of race and trust in tissue/blood donation for genetic research. Genet Med. 2010;12(2):116-121. doi:10.1097/GIM.0b013e3181cd6689
8. Hammond WP, Matthews D, Corbie-Smith G. Psychosocial factors associated with routine health examination scheduling and receipt among African American men. J Nat Med Assoc. 2010;102(4):276-289. doi:10.1016/S0027-9684(15)30600-3
9. Polinski JM, Kesselheim AS, Frolkis JP, Wescott P, Allen-Coleman C, Fischer MA. A matter of trust: patient barriers to primary medication adherence. Health Educ Res. 2014;29(5):755-763. doi:10.1093/her/cyu023
10. Galvan FH, Bogart LM, Klein DJ, Wagner GJ, Chen YT. Medical mistrust as a key mediator in the association between perceived discrimination and adherence to antiretroviral therapy among HIV-positive Latino men. J Behav Med. 2017;40(5):784-793. doi:10.1007/s10865-017-9843-1
11. Powell W, Richmond J, Mohottige D, Yen I, Joslyn A, Corbie-Smith G. Medical mistrust, racism, and delays in preventive health screening among African-American men. Behav Med. 2019;45(2):102-117. doi:10.1080/08964289.2019.1585327
12. Senft N, Hamel LM, Manning MA, et al. Willingness to discuss clinical trials among Black vs White men with prostate cancer. JAMA Oncol. 2020;6(11):1773-1777. doi:10.1001/jamaoncol.2020.3697
13. Thompson HS, Manning M, Mitchell J, et al. Factors associated with racial/ethnic group–based medical mistrust and perspectives on COVID-19 vaccine trial participation and vaccine uptake in the US. JAMA Netw Open. 2021;4(5):e2111629. doi:10.1001/jamanetworkopen.2021.11629
14. Orom H, Homish DL, Homish GG, Underwood W III. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among prostate cancer patients who chose active surveillance. Urol Oncol. 2014;32(4):396-402. doi:10.1016/j.urolonc.2013.09.018
15. Kao AC, Green DC, Zaslavsky AM, Koplan JP, Cleary PD. The relationship between method of physician payment and patient trust. JAMA. 1998;280(19):1708-1714. doi:10.1001/jama.280.19.1708
16. Alber K, Kuehlein T, Schedlbauer A, Schaffer S. Medical overuse and quaternary prevention in primary care – a qualitative study with general practitioners. BMC Fam Pract. 2017;18(1):99. doi:10.1186/s12875-017-0667-4
17. Herwig A, Dehnen D, Weltermann B. Patient factors driving overuse of cardiac catheterisation: a qualitative study with 25 participants from two German teaching practices. BMJ Open. 2019;9(4):e024600. doi:10.1136/bmjopen-2018-024600
18. Opdal PØ, Meland E, Hjörleifsson S. Dilemmas of medical overuse in general practice – a focus group study. Scand J Prim Health Care. 2019;37(1):135-140. doi:10.1080/02813432.2019.1569370
19. Ellen M, Perlman S, Horowitz E, Shach R, Catane R. Understanding physicians’ perceptions of overuse of health services in oncology. Med Care Res Rev. 2021;78(5):511-520. doi:10.1177/1077558720915112
20. Krot K, Rudawska I. How public trust in health care can shape patient overconsumption in health systems? the missing links. Int J Environ Res Public Health. 2021;18(8):3860. doi:10.3390/ijerph18083860
21. Fritz Z, Holton R. Too much medicine: not enough trust? J Med Ethics. 2019;45(1):31-35. doi:10.1136/medethics-2018-104866
22. Tarrant C, Dixon-Woods M, Colman AM, Stokes T. Continuity and trust in primary care: a qualitative study informed by game theory. Ann Fam Med. 2010;8(5):440-446. doi:10.1370/afm.1160
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Geographic Variations and Facility Determinants of Acute Care Utilization and Spending for ACSCs
November 12th 2024Emergency department (ED) visits and hospitalizations for ambulatory care–sensitive conditions (ACSCs) among Medicaid patients constitute almost 40% of all ED visits and hospitalizations, with lower rates observed in areas with greater proximity to urgent care facilities and density of rural health clinics.
Read More
Pervasiveness and Clinical Staff Perceptions of HPV Vaccination Feedback
November 11th 2024This article used regression analyses to quantify how clinical staff perceive provider feedback to improve human papillomavirus (HPV) vaccination rates and determine the prevalence of such feedback.
Read More